Therapeutic and Preventive Vaccine Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
The global
therapeutic and preventive vaccine market is
estimated to grow at an impressive growth rate of 9.3% during the forecast
period. Increasing funding for activities for DNA vaccinations is primarily
driving therapeutic and preventive vaccine market in North America. As an
instance, In January 2018, Bill and Melinda Gates Foundation has granted $1.4
million to the Wistar Institute (Philadelphia) to develop a synthetic DNA-based
vaccine for malaria. Wistar Institute will collaborate with the Inovia
Pharmaceuticals, Inc. and Johns Hopkins Malaria Research Center for this
research initiative.
With this research funding from the Gates Foundation, the
Wistar Institute along with its collaborating partners will plan to develop a
vaccine against Plasmodium falciparum. The synthetic vaccine is created to
instruct the body in order to produce malaria-specific antigens. As a result,
it will activate the immune system to create a highly effective immune
response. Such efforts drive the global therapeutic and preventive vaccine
market growth.
To Request a Sample of our Report on Therapeutic and
Preventive Vaccine Market: https://www.omrglobal.com/request-sample/therapeutic-and-preventive-vaccine-market
In addition, according to WHO,
in 2016, the governments of epidemic countries offered $800 million, accounting
for 31% of overall funding. The US was the major contributor to international
funding for a malaria control program in 2016. The country offered $1 billion
that accounted for 38% of whole malaria funding, followed by other key donors,
such as UK, France, Germany, and Japan.
According to the CDC (Centers for disease control and
prevention), nearly 1700 cases of malaria are reported in the US every year.
Such a higher prevalence of malaria is the major reason encouraging North
America to provide support to the companies for conducting research activities
that enable them to combat malaria; thereby, expanding global therapeutic and
preventive vaccine market size.
Strict Regulations in China
Mandating Vaccination is Expanding the Market Size of the Global Therapeutic
and Preventive Vaccine Market
In China, it is mandatory to inject the hepatitis B vaccine
(HBV) and tuberculosis-TB (BCG) vaccine immediately to the child after birth as
per Chinese law. This escalates the global therapeutic and preventive vaccine
market growth in China. China began its expanded program on Immunization (EPI)
in 1992. It involves a mandatory 11-vaccine schedule that must be given to
children from 0 to 6 years. The vaccination schedule is compulsory for Chinese
citizens.
The compulsory vaccines in China are Hepatitis B (HBV),
Japanese Encephalitis (JE) and Hepatitis A (HAV). Along with this, the
recommended vaccines are Chickenpox, Rotavirus, and Rabies. In 2014, WHO
renewed China’s National Regulatory Authority (CNRA) vaccine regulatory
oversight standards qualification. China’s Food and Drug Administration (CFDA)
under the CNRA issues vaccine-manufacturing had provided the license to 34
companies that meet the required international manufacturing practice
requirements.
(Get
15% Discount on Buying this Report)
A
full Report of Therapeutic and Preventive Vaccine Market is Available
at: https://www.omrglobal.com/industry-reports/therapeutic-and-preventive-vaccine-market
Current Market Trends
Covered in the Global Therapeutic and Preventive Vaccine Market Report
·
On the basis of the type, the preventive vaccine
segment is estimated to hold a dominating market share during the forecast
period.
·
North America is estimated to dominate the
global therapeutic and preventive vaccine industry during the forecast period.
Global
Therapeutic and Preventive Vaccine Market Segmentation
By
Type
·
Therapeutic Vaccine
·
Preventive Vaccine
By
End-User
·
Human
·
Animal
Regional
Analysis
North America
·
United
States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of
Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of
APAC
Rest of The
World
·
Middle
East & Africa
·
Latin
America
Company Profiles
·
Agenus Inc.
·
Argos Therapeutic Inc.
·
Astellas Pharma Inc.
·
AstraZeneca PLC
·
Celldex Therapeutic Inc.
·
CSL Ltd.
·
Cytos Biotechnology AG
·
Daiichi Sankyo Co. Ltd
·
Dendreon Corp
·
Emergent BioSolutions Inc.
·
GC Pharma (Green Cross Corp.)
·
GlaxoSmithKline PLC
·
Johnson & Johnson Services Inc.
·
Merck & Co.
·
Novartis International AG
·
Novavax Inc.
·
Pfizer Inc.
·
Qed Biosciences Inc.
·
Sanofi SA
·
Takeda Pharmaceutical Co. Ltd.
·
Vaccinogen Inc.
·
Xenetic Biosciences, Inc.
·
Zoetis Inc.
Reasons to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries
are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/therapeutic-and-preventive-vaccine-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment